Cedars-Sinai Medical Center, Los Angeles

Beth Y. Karlan, M.D. is Director of the Cedars-Sinai Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute and the Gilda Radner Hereditary Cancer Program. She is the recipient of the Pioneer in Medicine Award and holds the Board of Governors Endowed Chair in Gynecologic Oncology at Cedars-Sinai Medical Center. Her clinical practice and research focus on ovarian and other women’s cancers, as well as inherited cancer susceptibility and biomarker discovery for early detection and targeted treatment. She is passionate about improving care for women with cancer through cutting- edge clinical interventions and more rapid translation of scientific discoveries to the bedside. Dr. Karlan is a graduate of Harvard-Radcliffe College and Harvard Medical School, and serves on the Board of Overseers for Harvard University. She has testified before the U.S. Congress in support of increased funding for cancer research and for wider public dissemination of cancer risk information. She is an American Cancer Society Clinical Research Professor, a past president of the Society of Gynecologic Oncology, and Editor-in-Chief of the scientific journals Gynecologic Oncology and Gynecologic Oncology Reports. In 2012, Dr. Karlan was appointed by the White House to serve on the National Cancer Advisory Board and in 2015, she was elected to membership in the National Academy of Medicine, of the U.S. National Academies of Sciences, Engineering, and Medicine.